GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » EPS without NRI

Eusol Biotech Co (ROCO:6652) EPS without NRI : NT$-0.36 (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co EPS without NRI?

Eusol Biotech Co's earnings per share without non-recurring items for the six months ended in Jun. 2024 was NT$-0.11. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.36.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 25.30% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 30.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Eusol Biotech Co's EPS without NRI or its related term are showing as below:

ROCO:6652' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -12.9   Med: 19.45   Max: 46.7
Current: 25.3

During the past 9 years, Eusol Biotech Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 46.70% per year. The lowest was -12.90% per year. And the median was 19.45% per year.

ROCO:6652's 3-Year EPS without NRI Growth Rate is ranked better than
75.14% of 1239 companies
in the Biotechnology industry
Industry Median: 4.6 vs ROCO:6652: 25.30

Eusol Biotech Co's EPS (Diluted) for the six months ended in Jun. 2024 was NT$-0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.36.

Eusol Biotech Co's EPS (Basic) for the six months ended in Jun. 2024 was NT$-0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.36.


Eusol Biotech Co EPS without NRI Historical Data

The historical data trend for Eusol Biotech Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co EPS without NRI Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -0.86 -0.91 -0.92 -0.13 -0.38

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 0.13 -0.13 -0.25 -0.11

Competitive Comparison of Eusol Biotech Co's EPS without NRI

For the Biotechnology subindustry, Eusol Biotech Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's PE Ratio without NRI falls into.



Eusol Biotech Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eusol Biotech Co  (ROCO:6652) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Eusol Biotech Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines